Literature DB >> 24154542

Abnormal mitochondrial transport and morphology are common pathological denominators in SOD1 and TDP43 ALS mouse models.

Jordi Magrané1, Czrina Cortez, Wen-Biao Gan, Giovanni Manfredi.   

Abstract

Neuronal mitochondrial morphology abnormalities occur in models of familial amyotrophic lateral sclerosis (ALS) associated with SOD1 and TDP43 mutations. These abnormalities have been linked to mitochondrial axonal transport defects, but the temporal and spatial relationship between mitochondrial morphology and transport alterations in these two distinct genetic forms of ALS has not been investigated in vivo. To address this question, we crossed SOD1 (wild-type SOD1(WT) and mutant SOD1(G93A)) or TDP43 (mutant TDP43(A315T)) transgenic mice with mice expressing the fluorescent protein Dendra targeted to mitochondria in neurons (mitoDendra). At different time points during the disease course, we studied mitochondrial transport in the intact sciatic nerve of living mice and analyzed axonal mitochondrial morphology at multiple sites, spanning from the spinal cord to the motor terminals. Defects of retrograde mitochondrial transport were detected at 45 days of age, before the onset of symptoms, in SOD1(G93A) and TDP43(A315T) mice, but not in SOD1(WT). At later disease stages, also anterograde mitochondrial transport was affected in both mutant mouse lines. In SOD1(G93A) mice, mitochondrial morphological abnormalities were apparent at 15 days of age, thus preceding transport abnormalities. Conversely, in TDP43(A315T) mice, morphological abnormalities appeared after the onset of transport defects. Taken together, these findings demonstrate that neuronal mitochondrial transport and morphology abnormalities occur in vivo and that they are common denominators of different genetic forms of the ALS. At the same time, differences in the temporal and spatial manifestation of mitochondrial abnormalities between the two mouse models of familial ALS imply that different molecular mechanisms may be involved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24154542      PMCID: PMC3929084          DOI: 10.1093/hmg/ddt528

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  41 in total

1.  An adverse property of a familial ALS-linked SOD1 mutation causes motor neuron disease characterized by vacuolar degeneration of mitochondria.

Authors:  P C Wong; C A Pardo; D R Borchelt; M K Lee; N G Copeland; N A Jenkins; S S Sisodia; D W Cleveland; D L Price
Journal:  Neuron       Date:  1995-06       Impact factor: 17.173

2.  The ALS disease-associated mutant TDP-43 impairs mitochondrial dynamics and function in motor neurons.

Authors:  Wenzhang Wang; Li Li; Wen-Lang Lin; Dennis W Dickson; Leonard Petrucelli; Teng Zhang; Xinglong Wang
Journal:  Hum Mol Genet       Date:  2013-07-04       Impact factor: 6.150

3.  Massive mitochondrial degeneration in motor neurons triggers the onset of amyotrophic lateral sclerosis in mice expressing a mutant SOD1.

Authors:  J Kong; Z Xu
Journal:  J Neurosci       Date:  1998-05-01       Impact factor: 6.167

Review 4.  Overexpression of growth-associated proteins in the neurons of adult transgenic mice.

Authors:  P Caroni
Journal:  J Neurosci Methods       Date:  1997-01       Impact factor: 2.390

5.  The neuroprotective factor Wlds does not attenuate mutant SOD1-mediated motor neuron disease.

Authors:  Christine Vande Velde; Michael L Garcia; Xinghua Yin; Bruce D Trapp; Don W Cleveland
Journal:  Neuromolecular Med       Date:  2004       Impact factor: 3.843

6.  CuZn superoxide dismutase (SOD1) accumulates in vacuolated mitochondria in transgenic mice expressing amyotrophic lateral sclerosis-linked SOD1 mutations.

Authors:  D Jaarsma; F Rognoni; W van Duijn; H W Verspaget; E D Haasdijk; J C Holstege
Journal:  Acta Neuropathol       Date:  2001-10       Impact factor: 17.088

7.  Mutations in dynein link motor neuron degeneration to defects in retrograde transport.

Authors:  Majid Hafezparast; Rainer Klocke; Christiana Ruhrberg; Andreas Marquardt; Azlina Ahmad-Annuar; Samantha Bowen; Giovanna Lalli; Abi S Witherden; Holger Hummerich; Sharon Nicholson; P Jeffrey Morgan; Ravi Oozageer; John V Priestley; Sharon Averill; Von R King; Simon Ball; Jo Peters; Takashi Toda; Ayumu Yamamoto; Yasushi Hiraoka; Martin Augustin; Dirk Korthaus; Sigrid Wattler; Philipp Wabnitz; Carmen Dickneite; Stefan Lampel; Florian Boehme; Gisela Peraus; Andreas Popp; Martina Rudelius; Juergen Schlegel; Helmut Fuchs; Martin Hrabe de Angelis; Giampietro Schiavo; David T Shima; Andreas P Russ; Gabriele Stumm; Joanne E Martin; Elizabeth M C Fisher
Journal:  Science       Date:  2003-05-02       Impact factor: 47.728

8.  Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation.

Authors:  M E Gurney; H Pu; A Y Chiu; M C Dal Canto; C Y Polchow; D D Alexander; J Caliendo; A Hentati; Y W Kwon; H X Deng
Journal:  Science       Date:  1994-06-17       Impact factor: 47.728

9.  Amyotrophic lateral sclerosis is a distal axonopathy: evidence in mice and man.

Authors:  Lindsey R Fischer; Deborah G Culver; Philip Tennant; Albert A Davis; Minsheng Wang; Amilcar Castellano-Sanchez; Jaffar Khan; Meraida A Polak; Jonathan D Glass
Journal:  Exp Neurol       Date:  2004-02       Impact factor: 5.330

10.  Mutated human SOD1 causes dysfunction of oxidative phosphorylation in mitochondria of transgenic mice.

Authors:  Marina Mattiazzi; Marilena D'Aurelio; Carl D Gajewski; Katherine Martushova; Mahmoud Kiaei; M Flint Beal; Giovanni Manfredi
Journal:  J Biol Chem       Date:  2002-06-05       Impact factor: 5.157

View more
  150 in total

1.  Oligodendrocytes Death Induced Sensorimotor and Cognitive Deficit in N-nitro-L-arginine methyl Rat Model of Pre-eclampsia.

Authors:  Olayemi K Ijomone; Philemon Dauda Shallie; Thajasvarie Naicker
Journal:  Neurochem Res       Date:  2020-01-25       Impact factor: 3.996

Review 2.  Altered microtubule dynamics in neurodegenerative disease: Therapeutic potential of microtubule-stabilizing drugs.

Authors:  Kurt R Brunden; Virginia M-Y Lee; Amos B Smith; John Q Trojanowski; Carlo Ballatore
Journal:  Neurobiol Dis       Date:  2016-12-22       Impact factor: 5.996

3.  TDP-43 and PINK1 mediate CHCHD10S59L mutation-induced defects in Drosophila and in vitro.

Authors:  Minwoo Baek; Yun-Jeong Choe; Sylvie Bannwarth; JiHye Kim; Swati Maitra; Gerald W Dorn; J Paul Taylor; Veronique Paquis-Flucklinger; Nam Chul Kim
Journal:  Nat Commun       Date:  2021-03-26       Impact factor: 14.919

4.  Mitochondrial retrograde signalling in neurological disease.

Authors:  Lucy Granat; Rachel J Hunt; Joseph M Bateman
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2020-05-04       Impact factor: 6.237

Review 5.  TDP-43 proteinopathy and mitochondrial abnormalities in neurodegeneration.

Authors:  Ju Gao; Luwen Wang; Tingxiang Yan; George Perry; Xinglong Wang
Journal:  Mol Cell Neurosci       Date:  2019-08-21       Impact factor: 4.314

6.  Motor neuron mitochondrial dysfunction in spinal muscular atrophy.

Authors:  Nimrod Miller; Han Shi; Aaron S Zelikovich; Yong-Chao Ma
Journal:  Hum Mol Genet       Date:  2016-08-03       Impact factor: 6.150

7.  Modeling Axonal Defects in Hereditary Spastic Paraplegia with Human Pluripotent Stem Cells.

Authors:  Kyle R Denton; Chongchong Xu; Harsh Shah; Xue-Jun Li
Journal:  Front Biol (Beijing)       Date:  2016-09-28

8.  Analyzing Mitochondrial Transport and Morphology in Human Induced Pluripotent Stem Cell-Derived Neurons in Hereditary Spastic Paraplegia.

Authors:  Yongchao Mou; Sukhada Mukte; Eric Chai; Joshua Dein; Xue-Jun Li
Journal:  J Vis Exp       Date:  2020-02-09       Impact factor: 1.355

9.  Dyslipidemia impairs mitochondrial trafficking and function in sensory neurons.

Authors:  Amy E Rumora; Stephen I Lentz; Lucy M Hinder; Samuel W Jackson; Andrew Valesano; Gideon E Levinson; Eva L Feldman
Journal:  FASEB J       Date:  2017-09-13       Impact factor: 5.191

10.  ROS Control Mitochondrial Motility through p38 and the Motor Adaptor Miro/Trak.

Authors:  Valentina Debattisti; Akos A Gerencser; Masao Saotome; Sudipto Das; György Hajnóczky
Journal:  Cell Rep       Date:  2017-11-07       Impact factor: 9.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.